Clinical usefulness of cardiac biomarkers in hemodynamically stable pulmonary embolism

J Thromb Haemost. 2006 Mar;4(3):550-1. doi: 10.1111/j.1538-7836.2006.01826.x.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers / blood
  • Clinical Trials as Topic
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Natriuretic Peptide, Brain / blood*
  • Predictive Value of Tests
  • Pulmonary Embolism / blood*
  • Pulmonary Embolism / drug therapy
  • Pulmonary Embolism / mortality
  • Thromboembolism / blood
  • Thromboembolism / prevention & control
  • Thrombolytic Therapy*
  • Venous Thrombosis / blood
  • Venous Thrombosis / prevention & control
  • Ventricular Dysfunction, Right / blood*
  • Ventricular Dysfunction, Right / drug therapy
  • Ventricular Dysfunction, Right / mortality

Substances

  • Biomarkers
  • Fibrinolytic Agents
  • Natriuretic Peptide, Brain